These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 35214624)
1. Serum Level of Anti-Nucleocapsid, but Not Anti-Spike Antibody, Is Associated with Improvement of Long COVID Symptoms. Varnai R; Molnar T; Zavori L; Tőkés-Füzesi M; Illes Z; Kanizsai A; Csecsei P Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214624 [TBL] [Abstract][Full Text] [Related]
2. Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID Symptoms. Molnar T; Varnai R; Schranz D; Zavori L; Peterfi Z; Sipos D; Tőkés-Füzesi M; Illes Z; Buki A; Csecsei P J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640355 [TBL] [Abstract][Full Text] [Related]
3. Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection. Gerhards C; Thiaucourt M; Kittel M; Becker C; Ast V; Hetjens M; Neumaier M; Haselmann V Int J Infect Dis; 2021 Jun; 107():221-227. PubMed ID: 33932604 [TBL] [Abstract][Full Text] [Related]
4. Antibody responses to SARS-CoV-2 nucleocapsid and spike proteins in hospitalized patients with COVID-19: A multicenter, retrospective, cross-sectional study in Japan. Hibino M; Watanabe S; Tobe S; Maeda K; Horiuchi S; Nishiguchi S; Iwase A; Uryu K; Kobayashi S; Kondo T Respir Investig; 2022 Mar; 60(2):256-263. PubMed ID: 34924308 [TBL] [Abstract][Full Text] [Related]
5. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery. Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127 [TBL] [Abstract][Full Text] [Related]
6. The Incidence of Long-Term Fatigue in Patients Who Achieved Remission From COVID-19 at King Abdulaziz Medical City. Alotibi WM; Alzeer Z; Alfarhan IF; Alharbi AD; Alhaqbani FA; Almutairi AS; Alhazmi TM Cureus; 2023 Jan; 15(1):e33869. PubMed ID: 36819348 [TBL] [Abstract][Full Text] [Related]
7. Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer. Mueller T Clin Chim Acta; 2021 Jul; 518():9-16. PubMed ID: 33741357 [TBL] [Abstract][Full Text] [Related]
8. Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents. Koerber N; Priller A; Yazici S; Bauer T; Cheng CC; Mijočević H; Wintersteller H; Jeske S; Vogel E; Feuerherd M; Tinnefeld K; Winter C; Ruland J; Gerhard M; Haller B; Christa C; Zelger O; Roggendorf H; Halle M; Erber J; Lingor P; Keppler O; Zehn D; Protzer U; Knolle PA Nat Commun; 2022 Jan; 13(1):153. PubMed ID: 35013191 [TBL] [Abstract][Full Text] [Related]
10. Comparative Assessment of Sera from Individuals after S-Gene RNA-Based SARS-CoV-2 Vaccination with Spike-Protein-Based and Nucleocapsid-Based Serological Assays. Dörschug A; Frickmann H; Schwanbeck J; Yilmaz E; Mese K; Hahn A; Groß U; Zautner AE Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33802453 [TBL] [Abstract][Full Text] [Related]
11. IgG antibody titers against SARS-CoV-2 nucleocapsid protein correlate with the severity of COVID-19 patients. Yang L; Xu Q; Yang B; Li J; Dong R; Da J; Ye Z; Xu Y; Zhou H; Zhang X; Liu L; Zha Y; Yu F BMC Microbiol; 2021 Dec; 21(1):351. PubMed ID: 34922455 [TBL] [Abstract][Full Text] [Related]
12. Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients - the Vienna Cohort. Beilhack G; Monteforte R; Frommlet F; Gaggl M; Strassl R; Vychytil A Front Immunol; 2021; 12():780594. PubMed ID: 34925359 [TBL] [Abstract][Full Text] [Related]
13. Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients. Trougakos IP; Terpos E; Zirou C; Sklirou AD; Apostolakou F; Gumeni S; Charitaki I; Papanagnou ED; Bagratuni T; Liacos CI; Scorilas A; Korompoki E; Papassotiriou I; Kastritis E; Dimopoulos MA BMC Med; 2021 Aug; 19(1):208. PubMed ID: 34420521 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis. Yau K; Abe KT; Naimark D; Oliver MJ; Perl J; Leis JA; Bolotin S; Tran V; Mullin SI; Shadowitz E; Gonzalez A; Sukovic T; Garnham-Takaoka J; de Launay KQ; Takaoka A; Straus SE; McGeer AJ; Chan CT; Colwill K; Gingras AC; Hladunewich MA JAMA Netw Open; 2021 Sep; 4(9):e2123622. PubMed ID: 34473256 [TBL] [Abstract][Full Text] [Related]
15. Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection. Rosati M; Terpos E; Ntanasis-Stathopoulos I; Agarwal M; Bear J; Burns R; Hu X; Korompoki E; Donohue D; Venzon DJ; Dimopoulos MA; Pavlakis GN; Felber BK Front Immunol; 2021; 12():793953. PubMed ID: 34899762 [TBL] [Abstract][Full Text] [Related]
16. Measurement of SARS-CoV-2 Antibody Titers Improves the Prediction Accuracy of COVID-19 Maximum Severity by Machine Learning in Non-Vaccinated Patients. Kurano M; Ohmiya H; Kishi Y; Okada J; Nakano Y; Yokoyama R; Qian C; Xia F; He F; Zheng L; Yu Y; Jubishi D; Okamoto K; Moriya K; Kodama T; Yatomi Y Front Immunol; 2022; 13():811952. PubMed ID: 35126396 [TBL] [Abstract][Full Text] [Related]
17. Long-Term Humoral Immune Response against SARS-CoV-2 after Natural Infection and Subsequent Vaccination According to WHO International Binding Antibody Units (BAU/mL). Ruetalo N; Flehmig B; Schindler M; Pridzun L; Haage A; Reichenbächer M; Kirchner T; Kirchner T; Klingel K; Ranke MB; Normann A Viruses; 2021 Nov; 13(12):. PubMed ID: 34960605 [TBL] [Abstract][Full Text] [Related]